News | March 07, 2025
Medicamen Biotech partners with South African business conglomerate
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The company has withdrawn all litigation against Vikas Lifecare Limited post withdrawal of the Alwar Case by VLL
Earlier, Cupid Limited had been eligible to supply 75% of the contract for female condoms in previous tenders
This approval is a significant achievement in expanding the availability of this critical therapeutic,
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Subscribe To Our Newsletter & Stay Updated
